IJCRR - Vol 07 Issue 11, June, 2015
Antifungal Susceptibility of Candida against Six Antifungal Drugs by Disk Diffusion Method Isolated From Vulvovaginal Candidiasis
Author: Twinkle N. Gandhi, Manish G. Patel, Mannu R. Jain
Introduction: Vulvovaginal candidiasis is the second most common cause of vaginitis after bacterial vaginosis and is diagnosed in 40 % women with vaginal discharge. Incidence of fungal infections has increased dramatically over the past few decades. Epidemiologic data from the past decade reveal a paradigm shift in candida species from albicans to non -albicans candida species. The aim of this study was to determine incidence of vulvovaginal candidiasis, identify the species and test their in vitro susceptibility
profile against six antifungal agents – Fluconazole, Itraconazole, Ketoconazole, Clotrimazole, Amphotericin B and Nystatin. Material and Methods: Two high vaginal swabs were collected from patient with complain of vaginal discharge. One sample is processed for direct microscopic examination and other sample is used for culture on Sabourad’s dextrose agar and Blood agar. Isolates identified by battery of test and antifungal susceptibility testing of Candida species done by Disk Diffusion method. Results: A total of 122 isolates of candida species were obtained. Candida albicans was found to be the most frequently isolated species 81(66.39%) of the total isolates, followed by C. glabrata 19 (15.65%),C. tropicalis 12(33.61%), C. parapsilosis 6(4.91%), C. krusei 3(2.4%) and C. gullermondii 1(0.8%).Non-albicans candida constituted 41(33.61%).Antifungal susceptibility pattern showed that candida isolates were more sensitive to Nystatin and Amphotericin –B, compared to that of Clotrimazole, Fluconazole and Ketoconazole. 78% C. albicans were sensitive to Fluconazole, 5% were dose dependent susceptible, and 17% were resistant. C. krusei had shown 33% resistance against fluconazole and67% resistance against Clotrimazole. Conclusion: The majority of C. albicans isolates were susceptible to Fluconazole. C. krusei had shown maximum resistance among all the isolates. Identification of Candida to species level and their antifungal susceptibility testing should be done to achieve better clinical results.
Keywords: Vulvovaginal candidiasis (VVC), Antifungal susceptibility testing, Disk diffusion method
Twinkle N. Gandhi, Manish G. Patel, Mannu R. Jain. Antifungal Susceptibility of Candida against Six Antifungal Drugs by Disk Diffusion Method Isolated From Vulvovaginal Candidiasis International Journal of Current Research and Review. Vol 07 Issue 11, June, 20-25
1. Adesiji Y.O., N. Ndukwe, B. M. Okanlawon. C Isolation and Antifungal Sensitivity to Candida Isolates in Young Females. Central Europen Journal of Medicine. Accepted 21 September 2010.
2. Kelen F. D. Dota, Alessandra R. Freitas, Marcia E. L. Consolaro, Terezinha I. E. Svidzinski. A Challenge for Clinical Laboratories: Detection of Antifungal Resistance in Candida Species Causing Vulvovaginal Candidiasis. Journal of Labmedicine February 2011 Volume 42 Number 2
3. Dr. Ajitha Reddy, Dr. Maimoona Mustafa. Phenotypic identification of candida species and their susceptibility profile in patients with genitourinary candidiasis International Journal of Advanced Research (2014), Volume 2, Issue 12, 76-84.
4. Dharmik Preeti G., Gomashe A. V., Upadhyay V. G. Susceptibility Pattern of Various Azoles Against Candida Species Causing Vulvovaginal Candidiasis. The Journal of Obstetrics and Gynecology of India (March–April 2013) 63(2):135–137
5. Zahra Salehei , Zahra Seifi, Ali Zarei , Mahmoudabadi A .Sensitivity of Vaginal Isolates of Candida to Eight Antifungal Drugs Isolated From Ahvaz, Iran. Jundishapur J Microbiology. 2012;5(4):574-577.
6. Arul Sheeba Malar S., Viswanathan T., Malarvizhi A., Lavanya V, Moorthy K. Isolation, characterisation and antifungal susceptibility Pattern of Candida albicans and non albicans Candida from Integrated counseling and testing centre (ICTC) patients African Journal of Microbiology Research Vol. 6(31), pp. 6039-6048, 16 August, 2012.
7. Sachin C Deorukhkar, Santosh Saini. Vulvovaginal Candidiasis due to non albicans Candida: its species distribution and antifungal susceptibility profile Int. J. Curr. Microbiol App. Sci (2013) 2(12): x-xx .
8. Sherin M Emam, Abeer A Abo Elazm1 and Ahmed Walid A. Exoenzymes Production and Antifungal Susceptibility of Candida Species Isolated from Pregnant Women with Vulvovaginitis. Journal of American Science 2012;8(12).
9. Lata Patel, Jayashri Pethani, Palak Bhatia et al . Prevalence of Candida infection and its Antifungal susceptibility pattern in tertiary care hospital, Ahmedabad. National journal of Medical researchVol.2 Issue4 Oct-Dec 2012.
10. M. A. Pfaller, D. J. Diekema, 1D. L. Gibbs,V. A. Newell et al Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion journal of clinical microbiology, Apr. 2010, p. 1366–1377.
11. Chander J. Candidiasis. In: A textbook of Medical Mycology, 3rd ed. Mehta Publishers, New Delhi, 2009; 266-90.
12. Fran Fisher, Norma cook, Fundamentals of diagnostic mycology, Philadelphia. W.B saunders company 1998;197-222.
13. National Committee for clinical Laboratory standards. Metod for antifungal disk diffusion susceptibility for yeasts. Approved guidelines.2004.wayne.
14. Vandenbossche, I., Vaneechoutte, M., Vandevenne, M., Baere, T. D., and Verschraegen G. 2002. Susceptibility testing of fluconazole by the NCCLS broth macrodilution method, E- test, and disk diffusion for application in the routine laboratory. J ClinMicrobiol.40 (3): 918-921.
15. Arthur L. Barry and Steven D. Brown. Fluconazole Disk Diffusion Procedure for Determining Susceptibility of Candida Species journal of clinical microbiology, Sept. 1996, p. 2154–2157
16. Debora Moreira, Marcos Ereno Auler, Luciana da Silva Ruiz et al. Species Distribution and Antifungal Susceptibility Of Yeasts Isolated From Vaginal Mucosa. Rev Patol Trop Vol. 43 (1): 48-56. Jan.-Mar. 2014.
17. Deepa Babin, Subbannayya Kotigadde, P. Sunil Rao and T.V Rao. Clinico-mycological profile of vaginal candidiasis in a tertiary care hospital in Kerala. International Journal of Research in Biological Sciences 2013; 3(1): 55-59.
18. Keyvan Pakshir, Leila Bahaedinie, Zahra Rezaei et al. In vitro activity of six antifungal drugs against clinically important dermatophytes. Jundishapur Journal of Microbiology (2009); 2(4): 158-163.
19. E. E. Akortha, V. O. Nwaugo and N. O. Chikwe. Antifungal resistance among Candida species from patients with genitourinary tract infection isolated in Benin City, Edo state, Nigeria African Journal of Microbiology Research Vol. 3(11) pp. 694-699, November, 2009.
20. Parisa Badiee , Abdolvahab Alborzi , Mohammad Ali Davarpanahb et al. Distributions and Antifungal Susceptibility of Candida Species from Mucosal Sites in HIV Positive Patients Archives of Iranian Medicine, Volume 13, Number 4, July 2010.